Articles tagged with Personalized Medicine
The PD GENEration study has found that 13% of participants have a genetic form of Parkinson's disease, significantly higher than previous estimates. The study, which reached its goal of 15,000 participants ahead of schedule, provides insights into the genetics of the disease and its potential for precision medicine.
Researchers measured thousands of blood proteins and found signatures that can predict the onset of 67 diseases, including multiple myeloma and cardiovascular risks. The protein prediction models outperformed standard clinical information in predicting disease risk.
Developed by University of Tsukuba researchers, the wearable patch accurately measures insensible perspiration, allowing for real-time hydration monitoring. The patch also detects variations in pH levels and chemical components, making it a promising tool for dehydration management, stress monitoring, and disease detection.
Researchers at Osaka University have developed molecules that can correct improper splicing of a vital tumor suppressor gene in neuroendocrine cancers. The study demonstrates that these splice-switching oligonucleotides can significantly reduce viable cancer cells and tumor size in mice, suggesting a novel therapeutic approach for intr...
A new liquid biopsy method analyzes gene fragments in the bloodstream to detect and track cancer, enabling oncologists to tailor treatment approaches to individual patients. This non-invasive test can help monitor treatment success, detect cancer recurrence, and improve patient quality of life.
A first-of-its-kind study compared preventative therapy efficacy between two groups: gene therapy alone and in combination with risdiplam or nusinersen. Dual therapy showed promise in independent sitting outcomes, but not in walking age or muscle disease progression prevention.
A Kobe University study finds that a new treatment for neuromyelitis optica spectrum disorder shifts the balance of immune cells, increasing anti-inflammatory signals. The discovery may enable clinicians to determine treatment effectiveness and move towards personalized medicine for autoimmune diseases.
Telo-seq reveals dynamic mechanisms of telomeres in aging and cancer, providing new insights into their role in health and disease. The breakthrough method determines telomere length and sequence on individual chromosomes.
Hormonally.org provides free-to-access, evidence-based resources on women's hormonal health, empowering women to seek care, treatment, and support. The nonprofit addresses stigmas and misinformation surrounding women's hormonal issues, fostering a supportive online community for connection and shared decision-making.
This review bridges traditional wisdom and modern science to examine the safety, efficacy, and bioactivity of herbal medicines. It highlights successful case studies where herbal remedies enhance patient outcomes when used alongside conventional treatments.
The new law recognizes personalized medicine as a fundamental patient right, emphasizing individualized treatment and care. It sets a precedent for future health care innovations worldwide, integrating genomics, proteomics, and AI technologies.
The Ottawa Hospital is receiving a $59 million grant to boost Canada's capacity for life-saving biotherapeutics, including vaccines, gene therapies, and cell therapies. The funding will support the construction and operation of a world-class biomanufacturing facility at its new campus.
Hangbo Zhao's new research enables the development of soft, flexible microneedle electrodes that can sense into tissues and gain accurate results. The technology is enabled by a novel manufacturing process that combines laser micromachining, microfabrication, and transfer printing.
A new set of clinical practice standards and recommendations offers tailored and effective care for individuals with advanced and metastatic cancer. The initiative, backed by MASCC and ASCO, provides a critical resource to healthcare stakeholders.
A survey of healthcare providers in the Middle East reveals a good understanding of halal pharmaceuticals, but gaps in knowledge, particularly about ingredients and aligning with Islamic principles. Personalized education and culturally sensitive care can address patient concerns and improve healthcare outcomes for all patients.
Researchers at the University of Missouri have developed a soft, self-charging material that can track vital signs like blood pressure and heart activity wirelessly. This innovation has significant implications for early disease detection and timely interventions in chronic conditions.
The position paper identifies eight key areas for digital neuroscience research, including near-term, middle-term, and long-term goals. It also discusses the potential of 'digital twin' approaches, ultra-high-resolution digital atlases, and neuro-derived AI and computing innovations.
A study published in The Lancet Gastroenterology & Hepatology found that dietary adjustments, such as a low FODMAP diet and low-carbohydrate diets, resulted in significantly reduced IBS symptoms for over seven out of ten patients. In contrast, medication-based treatment showed fewer symptom improvements.
A groundbreaking treatment approach that combines genetic testing with individualized drug testing on tumor samples has shown promising results in treating relapsed pediatric cancer patients. The study achieved an impressive 83% improvement rate, including Logan Jenner's successful treatment after his leukemia relapse.
A new study found that access to genomic testing for cancer is limited by factors such as test availability, patient information, and insurance coverage in both Japan and Switzerland. Despite universal insurance coverage, barriers persist due to differences in hospital accessibility, language barriers, and varying levels of reimbursement.
Researchers have identified three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. These findings could lead to more effective and tailored treatment strategies for patients with the disease.
A team of Arizona State University scientists has developed an AI-based learning tool called HLA Inception that can classify individual proteins and predict immune responses. The tool uses machine learning to analyze electrostatic signatures on MHC-1 proteins, enabling faster predictions than traditional methods.
A retrospective cohort study found that PERT significantly reduced the incidence of acute pancreatitis episodes among children with recurrent or chronic pancreatitis. The study also identified genetic markers, such as SPINK1 mutation, that influence treatment outcomes and suggest a tailored approach to patient care.
A new study finds that objective information about preeclampsia risk could drive patient behavior change and motivate pregnant women to follow prevention strategies. The research highlights the potential of personalized risk data to improve pregnancy outcomes and reduce complications.
Researchers propose combining osimertinib with gefitinib to increase progression-free survival rates in EGFR-mutant lung cancer patients. A comprehensive PC approach could dramatically boost PFS for 80% of patients, eliminating harm and improving treatment outcomes.
Researchers developed a machine-learning model to assess prostate cancer biopsy samples, overcoming limitations of traditional methods. The new model, nnU-Net, provides accurate 3D segmentation of glandular tissue structures, leading to better prognostic analyses and potential improvements in patient outcomes.
Researchers from IOCB Prague and Ghent University have developed 3D-printable gelatin-based materials that can be easily monitored using X-rays or CT scans. This improvement enables the tracking of implant biodegradation and mechanical failures, allowing for tailored clinical requirements.
Researchers identified a putative paclitaxel response predictive biomarker for glioblastoma and breast cancer using the whole genome CRISPR knockout screen. The biomarker candidate was validated in two independent breast cancer patient cohorts that received taxane treatment.
The American Gastroenterological Association recommends fecal microbiota transplant (FMT) as a safe and effective treatment for most patients with recurrent Clostridioides difficile infection. FMT offers hope to patients suffering from debilitating C. diff, enabling them to lead happy and healthy lives.
A team of physicists and veterinary scientists at Purdue University has developed a method to detect chemoresistance in cancer patients using biodynamic imaging (BDI). This technique measures the motions inside cancer cells and how they respond to chemotherapy, identifying patients who will not respond to treatment. The study shows pro...
The Vilcek Foundation has awarded $250,000 to four immigrant scientists for their pioneering work in biomedical science. Luciano Marraffini, Gerta Hoxhaj, Tomasz Nowakowski, and Takanori Takebe are recognized for their contributions to cancer research, pluripotent stem cells, and CRISPR-Cas systems.
A multidisciplinary team created a new algorithm to provide optimal personalized treatment options for individuals with esophageal cancer. The framework uses various heterogeneous factors that facilitate the progression of the disease and demonstrated high accuracy in controlling esophageal cancer.
Researchers found that the brain's pain modulatory system changes with age and gender, making females more sensitive to moderate pain as they get older. The study used fMRI scans to examine brain responses in men and women aged 30-86 and identified a key role for the descending pain modulatory system.
A new tool, developed with a machine learning-based approach, can predict diuretic response in patients with ADHF. The BAN-ADHF score may lead to personalized strategies for effectively managing congestion in hospitalized patients.
Researchers developed a new chip that can detect cancer cells in blood samples, enabling clinicians to adapt treatments and improve outcomes for patients with lung cancer. The device traps and concentrates tiny numbers of cancer cells, allowing for regular monitoring of treatment effectiveness.
Researchers found that specific microbes in the gut reduce graft versus host disease after stem cell transplantation. Patients with low microbial metabolite risk index had better survival rates, fewer graft vs. host reactions, and reduced relapses.
Researchers explore the properties of cytostatic persisters in cancer treatment, highlighting their therapeutic potential and challenges. The study suggests that targeting these persisters before resistance emerges can reduce cancer recurrence.
Researchers developed GraphNovo, a program that provides accurate understanding of peptide sequences in cells, improving immunotherapy for unique cases. The AI model enhances de novo peptide sequencing accuracy, filling gaps with precise mass data.
Researchers uncover intricate interplay between enhancers and silencers influenced by DNA methylation, providing crucial insights into dynamic gene control. High-resolution mapping reveals how genes are controlled and modified, paving the way for precision medicine tailored to individual patients.
A new AI method combines satellite imaging and ecological analysis techniques to interpret large amounts of data from tumor tissue, providing insights into how cancer works. This approach aims to tailor cancer treatments to individual needs and avoid unnecessary side effects.
Scientists at the La Jolla Institute for Immunology have uncovered a group of T cells known as mucosal-associated invariant T (MAIT) cells. These cells can recognize the same markers whether they come from humans or mice, opening up new possibilities for treating infectious diseases and improving cancer immunotherapies. The study also ...
Researchers developed a technique to capture extracellular vesicles using sustainable wood cellulose-based nanofiber sheets, revealing new insights into cancer treatment. The technology has the potential to revolutionize early cancer diagnosis and open up personalized medicine.
A recent study published in Nature Communications validates MSIntuit CRC, an AI-driven digital pathology diagnostic, as a reliable pre-screening tool for colorectal cancer. The diagnostic accurately rules out nearly 50% of MSS patients while correctly classifying over 96% of MSI patients.
A new study found that precision medicine navigators can significantly increase genomic testing rates for Black patients with prostate cancer. Genomic testing is used to gauge the likelihood of cancer metastasis and has been shown to be more accurate than traditional tests in predicting treatment outcomes.
Veterinary researchers used 3D organoids to investigate lung cancer in dogs, finding that canine primary lung cancer organoids faithfully mirrored tumor tissues. The study identified correlations between organoid cell viability and specific target molecules, paving the way for personalized treatment approaches.
A Rice University-led team of researchers has been awarded $45 million to develop a new sense-and-respond implant technology that could improve immunotherapy outcomes for patients with difficult-to-treat cancers. The technology, called THOR, aims to provide real-time data from the tumor environment to guide more effective therapies.
A new editorial addresses clinician burnout by proposing a unifying systems medicine model that incorporates biological, psychological, environmental, and consciousness factors. The authors suggest that Transcendental Meditation can enhance resilience and prevent burnout-related mind-body conditions.
Researchers developed a platform that allows engineered biosensor bacteria to safely pass through the gastrointestinal tract in animal models. The platform enables real-time monitoring of gut health and can be used to diagnose and monitor various diseases, including inflammatory bowel disease. It has the potential to revolutionize pati...
Researchers aim to create machine learning tools that can analyze and quantify shape information from images, enabling more accurate diagnoses and improving patient care. A new family of deep neural networks, called DSNNs, will be developed to tackle AI's blind spot in image analysis.
A new open-source software, NMSM Pipeline, enables clinicians and engineers to create personalized computer models of patient movement to optimize treatment designs. The software uses physics-based models to predict and optimize functional outcomes for patients with various mobility impairments.
A Cochrane review reveals that organizational interventions can reduce the use of physical restraints in care home residents by 14%, without increasing falls or fall-related injuries. Supportive managers play a crucial role in implementing these interventions, which improve knowledge, skills, and strategies among frontline staff.
Researchers have uncovered almost 500 genes linked to diet, shedding light on genetic basis of food preferences. The findings suggest a potential for using genetics to develop precision nutrition strategies tailored to individual tastes.
A new UCLA Health study analyzed genetic data from 36,000 patients to identify disease risks and healthcare utilization among ancestrally diverse groups in the Los Angeles region. The research found substantial differences in diagnoses, hospital utilization, and genetic disease rates across clusters linked by shared genetic ancestry.
A large-scale study found that exercise programs for dialysis patients lead to significant improvements in physical fitness, quality of life, and reduced hospital stays. Personalized exercise plans showed low costs per training unit, making them a viable option for standard healthcare coverage.
Researchers discovered that Nerofe and Doxorubicin can downregulate KRAS signaling, leading to enhanced apoptosis in colorectal cancer cells. The combination also activates the immune system against tumor cells, increasing immunostimulatory cytokines and recruiting NK cells and M1 macrophages.
The global nuclear medicine initiative addresses the need for standardized educational curriculums to train physicians in nuclear theranostics procedures. The report highlights the rapid evolution of theranostic radiopharmaceuticals and emphasizes the importance of continuing medical education to maintain expertise.
The PanDrugs2 programme analyzes alterations in tumour genes, relates them to existing available drugs, and reports on the most suitable ones. It handles data on over 4,600 genes and 14,600 chemical compounds, generating information on around 74,000 associations between drugs and genes.
A multinational study identified immune resilience as a critical factor influencing life span, HIV/AIDS, flu, sepsis mortality, recurrent skin cancer, and COVID-19 mortality. Individuals with optimal levels of immune resilience were more likely to resist infections and recover from inflammatory stressors.
A powerful new stem cell technique has enabled large-scale studies of the relationship between human genetics and biology, accelerating research and potential personalized treatments.
A team of researchers discovered a process that helps breast cancer cells implant themselves in certain places in the body, leading to poorer prognosis. Overproduction of NNMT is key to metastasis, producing excessive collagen that enables cancer cells to survive and adapt.